AI revolution in insurance: bridging research and reality. [PDF]
Bhattacharya S+3 more
europepmc +1 more source
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt+7 more
wiley +1 more source
Abstract Despite the continued global prevalence of discourses of educational inclusion, young people across local, national and international contexts continue to be educated outside of mainstream schools. In England, a diverse market of providers—known as alternative provision (AP)—cater for many of these young people.
Jodie Pennacchia+3 more
wiley +1 more source
Does the trans-provincial immediate reimbursement reduce health gap between urban and rural floating population? Evidence from China. [PDF]
Tian J, Chen Z, Wang Y, Zhu Y.
europepmc +1 more source
Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand. [PDF]
Suwattanapreeda S+6 more
europepmc +1 more source
Does Climate Change Risk Impact Insurance Credit Risk? Cross Country Evidence
ABSTRACT While climate change poses a significant financial risk to the insurance industry, research has not yet examined the impact on the insurer's credit risk. This study investigates the impact of climate change risks on credit risk for insurance firms.
Jassem Alokla+2 more
wiley +1 more source
Factors influencing participation in colorectal cancer screening among average-risk populations: A descriptive-analytical study in a developing country. [PDF]
Rahimi F+4 more
europepmc +1 more source
Sustainability Performance and Its Impact on Financial Distress Risk—Evidence From STOXX Europe 600
ABSTRACT Sustainability performance (SP) has emerged as a central topic on both corporate and political agendas worldwide. This study investigated the relationship between SP and financial distress risk (FDR) among European listed firms, addressing the growing importance of SP in financial decision‐making.
Marcel Seefloth+4 more
wiley +1 more source
Navigating Nepal's health financing system: A road to universal health coverage amid epidemiological and demographic transitions. [PDF]
Khatri RB+4 more
europepmc +1 more source
ESG Disclosure and Access to Credit: A Configurational Analysis of European Listed Firms
ABSTRACT This study investigates how various ESG disclosure configurations affect credit access for European firms listed on the STOXX Europe 600 Index during 2021–2022. Employing fuzzy‐set qualitative comparative analysis and ESG disclosures standardised under the Global Reporting Initiative (GRI), the findings demonstrate that disclosure patterns ...
Carmen Gallucci+2 more
wiley +1 more source